These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34728330)

  • 21. Evaluation of non-animal methods for assessing skin sensitisation hazard: A Bayesian Value-of-Information analysis.
    Leontaridou M; Gabbert S; Van Ierland EC; Worth AP; Landsiedel R
    Altern Lab Anim; 2016 Jul; 44(3):255-69. PubMed ID: 27494625
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of a systems biology approach to skin allergy risk assessment.
    Maxwell G; Mackay C
    Altern Lab Anim; 2008 Nov; 36(5):521-56. PubMed ID: 19025322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Building confidence in skin sensitisation potency assessment using new approach methodologies: report of the 3rd EPAA Partners Forum, Brussels, 28th October 2019.
    Basketter D; Beken S; Bender H; Bridges J; Casati S; Corvaro M; Cuvellier S; Hubesch B; Irizar A; Jacobs MN; Kern P; Lamplmair F; Manou I; Müller BP; Roggeband R; Rossi LH
    Regul Toxicol Pharmacol; 2020 Nov; 117():104767. PubMed ID: 32866543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Applying the skin sensitisation adverse outcome pathway (AOP) to quantitative risk assessment.
    Maxwell G; MacKay C; Cubberley R; Davies M; Gellatly N; Glavin S; Gouin T; Jacquoilleot S; Moore C; Pendlington R; Saib O; Sheffield D; Stark R; Summerfield V
    Toxicol In Vitro; 2014 Feb; 28(1):8-12. PubMed ID: 24184331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The SCCS Notes of Guidance for the testing of cosmetic ingredients and their safety evaluation, 11th revision, 30-31 March 2021, SCCS/1628/21.
    ;
    Regul Toxicol Pharmacol; 2021 Dec; 127():105052. PubMed ID: 34653552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accelerating the Pace of Chemical Risk Assessment.
    Kavlock RJ; Bahadori T; Barton-Maclaren TS; Gwinn MR; Rasenberg M; Thomas RS
    Chem Res Toxicol; 2018 May; 31(5):287-290. PubMed ID: 29600706
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beyond dermal exposure: The respiratory tract as a target organ in hazard assessments of cosmetic ingredients.
    Thá EL; Canavez ADPM; Schuck DC; Gagosian VSC; Lorencini M; Leme DM
    Regul Toxicol Pharmacol; 2021 Aug; 124():104976. PubMed ID: 34139277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systematic evaluation of non-animal test methods for skin sensitisation safety assessment.
    Reisinger K; Hoffmann S; Alépée N; Ashikaga T; Barroso J; Elcombe C; Gellatly N; Galbiati V; Gibbs S; Groux H; Hibatallah J; Keller D; Kern P; Klaric M; Kolle S; Kuehnl J; Lambrechts N; Lindstedt M; Millet M; Martinozzi-Teissier S; Natsch A; Petersohn D; Pike I; Sakaguchi H; Schepky A; Tailhardat M; Templier M; van Vliet E; Maxwell G
    Toxicol In Vitro; 2015 Feb; 29(1):259-70. PubMed ID: 25448812
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
    Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Skin Sensitisation of Cosmetic Ingredients: Review of Actual Regulatory Status.
    Bialas I; Zelent-Kraciuk S; Jurowski K
    Toxics; 2023 Apr; 11(4):. PubMed ID: 37112619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reference Chemical Potency List (RCPL): A new tool for evaluating the accuracy of skin sensitisation potency measurements by New Approach Methodologies (NAMs).
    Irizar A; Bender H; Griem P; Natsch A; Vey M; Kimber I
    Regul Toxicol Pharmacol; 2022 Oct; 134():105244. PubMed ID: 35932886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Final report of the safety assessment of L-Ascorbic Acid, Calcium Ascorbate, Magnesium Ascorbate, Magnesium Ascorbyl Phosphate, Sodium Ascorbate, and Sodium Ascorbyl Phosphate as used in cosmetics.
    Elmore AR
    Int J Toxicol; 2005; 24 Suppl 2():51-111. PubMed ID: 16154915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. From xenobiotic chemistry and metabolism to better prediction and risk assessment of skin allergy.
    Smith Pease CK
    Toxicology; 2003 Oct; 192(1):1-22. PubMed ID: 14511899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: skin irritation.
    Macfarlane M; Jones P; Goebel C; Dufour E; Rowland J; Araki D; Costabel-Farkas M; Hewitt NJ; Hibatallah J; Kirst A; McNamee P; Schellauf F; Scheel J
    Regul Toxicol Pharmacol; 2009 Jul; 54(2):188-96. PubMed ID: 19393278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current opinion on risk assessment of cosmetics.
    Kim KB; Kwack SJ; Lee JY; Kacew S; Lee BM
    J Toxicol Environ Health B Crit Rev; 2021 May; 24(4):137-161. PubMed ID: 33832410
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Next Generation Risk Assessment of the Anti-Androgen Flutamide Including the Contribution of Its Active Metabolite Hydroxyflutamide.
    van Tongeren TCA; Carmichael PL; Rietjens IMCM; Li H
    Front Toxicol; 2022; 4():881235. PubMed ID: 35722059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coumarin metabolism, toxicity and carcinogenicity: relevance for human risk assessment.
    Lake BG
    Food Chem Toxicol; 1999 Apr; 37(4):423-53. PubMed ID: 10418958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alternatives to the use of animals in safety testing as required by the EU-Cosmetics Directive 2009.
    Vogel R
    ALTEX; 2009; 26(3):223-6. PubMed ID: 19907908
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alternatives for skin sensitisation: Hazard identification and potency categorisation: Report from an EPAA/CEFIC LRI/Cosmetics Europe cross sector workshop, ECHA Helsinki, April 23rd and 24th 2015.
    Basketter D; Ashikaga T; Casati S; Hubesch B; Jaworska J; de Knecht J; Landsiedel R; Manou I; Mehling A; Petersohn D; Rorije E; Rossi LH; Steiling W; Teissier S; Worth A
    Regul Toxicol Pharmacol; 2015 Nov; 73(2):660-6. PubMed ID: 26456663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coumarin derivatives, but not coumarin itself, cause skin irritation via topical delivery.
    Pan TL; Wang PW; Aljuffali IA; Leu YL; Hung YY; Fang JY
    Toxicol Lett; 2014 Apr; 226(2):173-81. PubMed ID: 24561300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.